ENPP1
Showing 1 - 17 of 17
Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Not yet recruiting
- Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
- +2 more
- INZ-701
- Control Arm (Conventional Therapy)
- (no location specified)
Sep 18, 2023
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Not yet recruiting
- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- +2 more
- (no location specified)
Feb 15, 2023
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Recruiting
- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- +2 more
-
Rochester, Minnesota
- +2 more
Jan 4, 2022
Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
Completed
- Generalized Arterial Calcification in Infancy
- Autosomal Recessive Hypophosphatemic Rickets Type 2
-
Eagan, MinnesotaEngage Health
Mar 30, 2021
ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum, Generalized Arterial Calcification of Infancy
Recruiting
- ATP-Binding Cassette Subfamily C Member 6 Deficiency
- +2 more
-
Eatontown, New Jersey
- +1 more
Jan 12, 2022
People With Generalized Arterial Calcification of Infancy or
Completed
- Generalized Arterial Calcification of Infancy
- Autosomal Recessive Hypophosphatemic Rickets Type2
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Serum autotaxin Level in Colorectal Cancer
Completed
- Colo-rectal Cancer
- Serum autotaxın levels
-
Ankara, TurkeyDışkapı Yıldırım Beyazıt training and research hospital
Oct 14, 2023
Relapsed/Refractory Multiple Myeloma Trial in Baltimore (Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
-
Baltimore, MarylandUniversity of Maryland
Jan 24, 2022
Newly Diagnosed Type 2 Diabetes Trial in Parma (Metformin-Sitagliptin-Empaglifozin-Pioglitazone, Standard of care)
Recruiting
- Newly Diagnosed Type 2 Diabetes
- Metformin-Sitagliptin-Empaglifozin-Pioglitazone
- Standard of care
-
Parma, ItalyAzienda Ospedaliero Universitaria di Parma
Aug 10, 2021
Natural History of GACI With or Without ARHR2 or PXE
Unknown status
- Generalized Arterial Calcification in Infancy
- +2 more
- No intervention
-
Münster, GermanyWWU Munster
Nov 28, 2018
Breast Cancer Trial (diagnostic test, radiation, other)
Unknown status
- Breast Cancer
- Serum Autotaxin
- +10 more
- (no location specified)
Mar 30, 2020
Type 2 Diabetes Trial in Philadelphia (PCD, DSE)
Completed
- Type 2 Diabetes
- PCD
- DSE
-
Philadelphia, Pennsylvania
- +1 more
Jun 28, 2013